Embecta (EMBC) Asset Writedowns and Impairment (2020 - 2026)

Embecta's (EMBC) quarterly Asset Writedowns and Impairment came in at $500000.0 in Q1 2026, up 104.72% quarter-over-quarter from -$10.6 million in Q3 2025.

Embecta (EMBC) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends

Embecta has disclosed Asset Writedowns and Impairment across 6 years of filings, most recently posting $500000.0 for Q1 2026.

  • Asset Writedowns and Impairment for Q1 2026 came in at $500000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$9.9 million (down 195.19% YoY), and the FY2023 annual result was $2.5 million, down 95.76% from the prior year.
  • Asset Writedowns and Impairment came in at $500000.0 for Q1 2026 at Embecta, up from -$10.6 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $58.9 million in Q3 2022 to a low of -$10.6 million in Q3 2025.
  • The 4-year median for Asset Writedowns and Impairment is $500000.0 (2026), against an average of $11.9 million.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn
10 Embecta 183.23 Mn -10.17 Mn 127.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 500,000.00
Mar 31, 2026 500,000.00
Sep 30, 2025 -10.60 Mn
Sep 30, 2025 -10.60 Mn
Jun 30, 2025 200,000.00
Jun 30, 2025 200,000.00
Dec 31, 2024 10.40 Mn
Dec 31, 2024 10.40 Mn
Sep 30, 2022 58.90 Mn
Sep 30, 2022 58.90 Mn
Jun 30, 2021 3.80 Mn
Jun 30, 2021 3.80 Mn
Dec 31, 2020 10.00 Mn
Dec 31, 2020 10.00 Mn